Kai Liang
Zhejiang A & F University(CN)Shandong University(CN)Peking University(CN)Sir Run Run Shaw Hospital(CN)Qilu Hospital of Shandong University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolism, Diabetes, and Cancer, Liver Disease Diagnosis and Treatment, Diabetes Management and Research, Pancreatic function and diabetes
Most-Cited Works
- → Mesenchymal stromal cells ameliorate oxidative stress-induced islet endothelium apoptosis and functional impairment via Wnt4-β-catenin signaling(2017)62 cited
- → Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic Activity(1995)52 cited
- → Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation(2023)50 cited
- → Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1(2021)48 cited
- → Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes(2016)37 cited
- → Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients